This could be a game changer. 
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
 


<[link removed]>

John,

Since the beginning of the pandemic, there has been hope that we could one
day fight COVID simply by taking a pill.

Among the first to be developed and tested is called Molnupiravir. It's a
hard-to-pronounce (but easy-to-swallow) antiviral tablet that, so far, has
proven effective at reducing severe disease and hospitalizations.

Dr. Andrew Pekosz, an immunologist and a professor at Johns Hopkins Bloomberg
School of Public Health, discussed the potential of the new drug for our Road
to Recovery series. Will you take a moment to watch?
<[link removed]>


<[link removed]>

WATCH NOW
<[link removed]>

SHARE ON FACEBOOK
<[link removed]>

SHARE ON TWITTER
<[link removed]>

SHARE ON LINKEDIN
<[link removed]>
Until now, the only effective antiviral treatment had to be administered
through a shot or IV. Having a widely available COVID pill could be a game
changer in the fight against the disease -- and another important scientific
advance in the effort to end the pandemic.

Watch our Road to Recovery video to hear how it works, find out who has
access to the pill today, and what it might mean for treating and potentially
preventing the spread of COVID in the future.


[link removed]

<[link removed]>

Thanks,

Bloomberg Philanthropies

 

<[link removed]>
<[link removed]>
<[link removed]>
<[link removed]>
<[link removed]>  
About our work

Bloomberg Philanthropies invests in 810 cities and 170 countries around the
world to ensure better, longer lives for the greatest number of people. The
organization focuses on five key areas for creating lasting change: Public
Health, Education, Government Innovation, Environment, and the Arts.


<[link removed]>
Public Health

<[link removed]>
Education

<[link removed]>
Government
Innovation

<[link removed]>
Environment

<[link removed]>
The Arts

Bloomberg Philanthropies encompasses all of Michael R. Bloomberg's giving,
including his foundation, corporate, and personal philanthropy as well as
Bloomberg Associates, a pro bono consultancy that works in cities around the
world. In 2020, Bloomberg Philanthropies distributed $1.6 billion.

Learn more at Bloomberg.org
<[link removed]>

Click here to unsubscribe
<[link removed]>
.

Bloomberg Philanthropies

All content ©2021 Bloomberg IP Holdings LLC. All rights reserved.